Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-19 Sale | 2021-07-20 8:51 pm | Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer | 3,945 | $6.45 | $25,445 | 141,241 (Direct) | View |
| 2021-07-19 Sale | 2021-07-20 8:49 pm | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 3,944 | $6.45 | $25,439 | 146,362 (Indirect Direct) | View |
| 2021-07-19 Sale | 2021-07-20 8:48 pm | Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer | 1,870 | $6.45 | $12,062 | 103,666 (Direct) | View |
| 2021-07-19 Sale | 2021-07-20 8:45 pm | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel | 3,945 | $6.45 | $25,445 | 133,486 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-19 Equity Swap | 2021-11-23 7:00 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Newtyn Management LLC 10% Owner | 5,900,000 | $0 | 0 (Indirect) | View |
Ownership | 2021-11-23 6:57 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Newtyn Management LLC 10% Owner | 0 | $0 | 5,900,000 (Indirect) | View |
| 2021-11-19 Disposition | 2021-11-19 10:20 am | N/A 2026-09-12 | Flexion Therapeutics Inc | FLXN | Stejbach Mark Director | 76,500 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:20 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Stejbach Mark Director | 12,631 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:19 am | N/A 2024-03-02 | Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director | 82,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:19 am | N/A N/A | Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director | 27,450 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:17 am | N/A 2024-06-10 | Flexion Therapeutics Inc | FLXN | MERRIFIELD C ANN Director | 91,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:17 am | N/A N/A | Flexion Therapeutics Inc | FLXN | MERRIFIELD C ANN Director | 19,000 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:16 am | N/A 2025-06-16 | Flexion Therapeutics Inc | FLXN | Lukatch Heath Director | 48,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:16 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Lukatch Heath Director | 9,000 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:14 am | N/A 2030-08-17 | Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director | 39,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:14 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director | 4,500 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:13 am | N/A 2031-07-08 | Flexion Therapeutics Inc | FLXN | Koppikar Utpal Director | 32,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:12 am | N/A 2024-03-02 | Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director | 82,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:12 am | N/A N/A | Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director | 1,496,564 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:10 am | N/A 2025-03-03 | Flexion Therapeutics Inc | FLXN | Canute Scott A Director | 91,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:10 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Canute Scott A Director | 9,000 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:09 am | N/A 2024-03-02 | Flexion Therapeutics Inc | FLXN | MAHAFFY PATRICK J Director | 133,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:09 am | N/A N/A | Flexion Therapeutics Inc | FLXN | MAHAFFY PATRICK J Director | 39,824 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:08 am | N/A 2027-06-25 | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel | 211,833 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:08 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel | 133,486 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:06 am | N/A 2026-09-11 | Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer | 112,667 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:06 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer | 103,666 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:04 am | N/A 2024-11-02 | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 185,833 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:04 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 146,843 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:03 am | N/A 2030-03-31 | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 50,100 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:03 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 103,956 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:01 am | N/A 2023-07-18 | Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer | 209,663 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:01 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer | 141,241 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:00 am | N/A 2031-05-31 | Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer | 168,000 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 10:00 am | N/A N/A | Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer | 30,680 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 09:58 am | N/A 2031-08-01 | Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer | 205,500 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 09:58 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer | 34,250 | $8.5 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 09:56 am | N/A 2023-07-18 | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,474,297 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-19 09:56 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,122,550 | $8.5 | 0 (Direct) | View |
| 2021-08-02 Option Award | 2021-08-04 4:09 pm | N/A 2031-08-01 | Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer | 239,750 | $0 | 239,750 (Direct) | View |
| 2021-07-19 Tax Withholding | 2021-07-20 8:44 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 13,859 | $0 | 1,122,033 (Direct) | View |
| 2021-07-09 Option Award | 2021-07-12 4:06 pm | N/A 2031-07-08 | Flexion Therapeutics Inc | FLXN | Koppikar Utpal Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:42 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director | 11,500 | $0 | 11,500 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:40 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | MERRIFIELD C ANN Director | 11,500 | $0 | 26,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:38 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | Canute Scott A Director | 11,500 | $0 | 16,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:32 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director | 11,500 | $0 | 1,503,564 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:30 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | Stejbach Mark Director | 11,500 | $0 | 19,631 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:25 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | Lukatch Heath Director | 11,500 | $0 | 16,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:24 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | MAHAFFY PATRICK J Director | 17,000 | $0 | 52,324 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:16 pm | N/A 2031-06-23 | Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director | 11,500 | $0 | 34,450 (Direct) | View |
| 2021-06-21 Option Award | 2021-06-28 6:13 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer | 2,081 | $7.78 | 105,536 (Direct) | View |
| 2021-06-21 Option Award | 2021-06-28 6:09 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 539 | $7.78 | 150,306 (Direct) | View |
| 2021-06-21 Option Award | 2021-06-28 6:04 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,700 | $7.78 | 1,135,892 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 4:20 pm | N/A 2031-05-31 | Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer | 196,000 | $0 | 198,680 (Direct) | View |